Guangdong Tai'an Tang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or major omissions.
Special Reminder:
- The Company's stock will be delisted on the trading day following the end of the delisting adjustment period.
- The start date for the delisting adjustment period is June 14, 2024, lasting for fifteen trading days, with the expected last trading date on July 4, 2024.
- The Company's stock will trade for fifteen trading days during the delisting adjustment period. The announcement date (July 4, 2024) is the 15th trading day and the last trading day. The stock will be delisted after this period, and investors are advised to invest cautiously and pay attention to risks.
- During the delisting adjustment period, the Company will not plan or implement any major asset restructuring matters.
- Investors, securities companies, and other market participants should settle stock pledge repurchase, agreed repurchase, margin financing, transfer, and Shenzhen Stock Connect businesses before the stock is delisted.
- For judicial freeze businesses expiring after the stock is delisted and before the completion of the initial registration in the delisting sector, it is recommended that the competent authorities handle the renewal procedures in advance through the original assistance execution channels before the stock is delisted.